UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000017881
Receipt number R000018730
Scientific Title Association between vascular calcification and exostosin-like glycosaminotransferase 2 (EXTL2) in hemodialysis patients
Date of disclosure of the study information 2015/06/15
Last modified on 2020/06/25 17:36:22

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Association between vascular calcification and exostosin-like glycosaminotransferase 2 (EXTL2) in hemodialysis patients

Acronym

Association between vascular calcification and EXTL2

Scientific Title

Association between vascular calcification and exostosin-like glycosaminotransferase 2 (EXTL2) in hemodialysis patients

Scientific Title:Acronym

Association between vascular calcification and EXTL2

Region

Japan


Condition

Condition

Chronic Kidney Disease

Classification by specialty

Nephrology

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

To investigate whether EXTL2 is associated with vascular calcification in hemodialysis patients

Basic objectives2

Others

Basic objectives -Others

Association between EXTL2 and vascular calcification

Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

Association between EXTL2 and abdominal calcification index (ACI)

Key secondary outcomes

1, Association between EXTL2 and chondroitin sulfate or heparan sulfate
2, Association between serum EXTL2 levels and EXTL2 mRNA in blood
3, Association between EXTL2 and other parameters
4, Difference of serum EXTL2 levels between healthy control and hemodialysis patients
5, Association between vascular calcification and chondroitin sulfate or heparan sulfate


Base

Study type

Observational


Study design

Basic design


Randomization


Randomization unit


Blinding


Control


Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms


Purpose of intervention


Type of intervention


Interventions/Control_1


Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit

20 years-old <=

Age-upper limit


Not applicable

Gender

Male and Female

Key inclusion criteria

hemodialysis patients

Key exclusion criteria

1, Inpatients
2, Patients who started hemodialysis within 6 months
3, Diabetic patients
4, Patients whose diameter of abdominal aorta is over three centimeters
5, Patients with surgical history of abdominal aorta
6, Patients who do not agree with participation in this study

Target sample size

20


Research contact person

Name of lead principal investigator

1st name
Middle name
Last name Shunsuke Goto

Organization

Kobe University Graduate School of Medicine

Division name

Division of Nephrology and Kidney Center

Zip code


Address

7-5-2, Kusuhoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-6500

Email

sgoto@med.kobe-u.ac.jp


Public contact

Name of contact person

1st name
Middle name
Last name Shunsuke Goto

Organization

Kobe University Graduate School of Medicine

Division name

Division of Nephrology and Kidney Center

Zip code


Address

7-5-2, Kusuhoki-cho, Chuo-ku, Kobe, Japan

TEL

078-382-6500

Homepage URL


Email

sgoto@med.kobe-u.ac.jp


Sponsor or person

Institute

Division of Nephrology and Kidney Center, Kobe University Graduate School of Medicine

Institute

Department

Personal name



Funding Source

Organization

Japanese Association of Dialysis Physicians

Organization

Division

Category of Funding Organization

Other

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization


Address


Tel


Email



Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions

社会医療法人愛仁会千船病院(大阪府)


Other administrative information

Date of disclosure of the study information

2015 Year 06 Month 15 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

27

Results


Results date posted


Results Delayed

Delay expected

Results Delay Reason

We require time to complete the paper.

Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Completed

Date of protocol fixation

2015 Year 06 Month 04 Day

Date of IRB

2015 Year 06 Month 03 Day

Anticipated trial start date

2015 Year 06 Month 15 Day

Last follow-up date

2015 Year 12 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information

Prospective study


Management information

Registered date

2015 Year 06 Month 11 Day

Last modified on

2020 Year 06 Month 25 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000018730


Research Plan
Registered date File name

Research case data specifications
Registered date File name

Research case data
Registered date File name